Evidence map›Paper›PMID 21807053›Full record

ArticleVaccine2011

Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites.

Satish Mishra, Urvashi Rai, Takayuki Shiratsuchi, Xiangming Li, Yannick Vanloubbeeck, Joe Cohen, Ruth S Nussenzweig, Elizabeth A Winzeler, Moriya Tsuji, Victor Nussenzweig

Abstract read
In one paragraph

Article in Vaccine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Profiling the Targets of Protective CD8Molecular therapy. Methods & clinical development · 2017
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Satish MishraMichael Heidelberger Division, Department of Pathology, New York University School of Medicine, NY 10016, United States. satish.mishra@nyumc.org
Urvashi Rai
Takayuki Shiratsuchi
Xiangming Li
Yannick Vanloubbeeck
Joe Cohen
Ruth S Nussenzweig
Elizabeth A Winzeler
Moriya Tsuji
Victor Nussenzweig
Aaron Diamond AIDS Research Center · USNew York University · USGlaxoSmithKline (Belgium) · BEGlaxoSmithKline (United Kingdom) · GBRockefeller University · USScripps Research Institute · US

Funding

Discovery of chemically validated malaria liver stage targetsR01AI090141 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WINZELER, ELIZABETH A · 2011 to 2019
$3.4M
Experimental Annotation of the P. Falciparum GenomeR01AI059472 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WINZELER, ELIZABETH A · 2005 to 2009
$2.2M
Novel Humanized Mice to Study CD1b/c-Mediated ImmunityR21AI062842 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI TSUJI, MORIYA · 2005 to 2006
$624k
Improving Malaria Pre-Erythrocytic VaccinesR56AI073658 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI TSUJI, MORIYA · 2008 to 2008
$461k
NIAID NIH HHS R01 AI059472NIAID NIH HHS R01AI059472NIAID NIH HHS R01 AI090141NIAID NIH HHS R21 AI062842NIAID NIH HHS R56 AI073658
6 · The paper itself

Abstract

Immunization of BALB/c mice with irradiated sporozoites (IrSp) of Plasmodium yoelii can lead to sterile immunity. The circumsporozoite protein (CSP) plays a dominant role in protection. Nevertheless after hyper-immunization with IrSp, complete protection is obtained in CSP-transgenic BALB/c mice that are T-cell tolerant to the CSP and cannot produce antibodies [CSP-Tg/JhT(-/-)]. This protection is mediated exclusively by CD8(+) T cells [1]. To identify the non-CSP protective T cell antigens, we studied the properties of 34 P. yoelii sporozoite antigens that are predicted to be secreted and to contain strong Kd-restricted CD8(+) T cell epitopes. The synthetic peptides corresponding to the epitopes were used to screen for the presence of peptide-specific CD8(+) T cells secreting interferon-γ (IFN-γ) in splenocytes from CSP-Tg/JhT(-/-) BALB/c mice hyper immunized with IrSp. However, the numbers of IFN-γ-secreting splenocytes specific for the non-CSP antigen-derived peptides were 20-100 times lower than those specific for the CSP-specific peptide. When mice were immunized with recombinant adenoviruses expressing selected non-CSP antigens, the animals were not protected against challenge with P. yoelii sporozoites although large numbers of CD8(+) specific T cells were generated.

Indexed as

AdenoviridaeAnimalsAntigens, ProtozoanCD8-Positive T-LymphocytesEpitopes, T-LymphocyteFemaleImmunizationInterferon-gammaMalariaMalaria VaccinesMiceMice, Inbred BALB CMice, TransgenicPlasmodium yoeliiProtozoan ProteinsSporozoitesAntigens, Protozoancircumsporozoite protein, ProtozoanEpitopes, T-LymphocyteInterferon-gammaMalaria VaccinesProtozoan Proteins

Identifiers

PMID21807053
PMCPMC3603353
OpenAlexW2035641129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.